Development of Novel Biotechnological Approaches for The Diagnosis and Nanotechnology-Based Treatment of Pediatric Acute Lymphoblastic Leukemia: an Integrated Molecular Investigation

Pediatric acute lymphoblastic leukemia (ALL) is a biologically heterogeneous hematological malignancy characterized by the abnormal proliferation of immature lymphoid cells. Although improvements in molecular classification, measurable residual disease (MRD) monitoring, and chemotherapy have substantially improved outcomes, challenges remain in detecting molecular subtypes, monitoring treatment response, and reducing treatment-associated toxicity. This study was designed to develop an integrated molecular diagnostic and nanotechnology-based therapeutic approach for pediatric B-cell acute lymphoblastic leukemia (B-ALL). A molecular assay framework was established for detecting selected leukemia-associated fusion transcripts, including ETV6::RUNX1, BCR::ABL1, TCF3::PBX1, and KMT2A-rearranged transcripts. Daunorubicin-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles were prepared using an oil-in-water emulsion-solvent evaporation method and evaluated using DLS, zeta-potential analysis, TEM, and FTIR. NALM-6 B-ALL cells were used as a leukemia cell model, while a non-malignant cell model was included to assess preliminary selectivity. In the illustrative dataset, daunorubicin-loaded PLGA nanoparticles had a mean hydrodynamic diameter of 186.4 ± 8.7 nm, a polydispersity index of 0.19 ± 0.03, and a zeta potential of −21.6 ± 2.4 mV. The molecular assay framework showed illustrative sensitivities of 95.0–100% and specificities of 96.0–100%, depending on the target. Nanoparticle-associated daunorubicin produced concentration-dependent reductions in NALM-6 cell viability and increased Annexin V-positive cells, with increased BAX and CASP3 expression and decreased BCL2 expression. Drug release was greater under the simulated acidic condition (pH 5.5) than at pH 7.4. These findings are hypothetical and require experimental validation. Further investigation using independent patient samples, multiple leukemia cell lines, and appropriate in vivo models is necessary before diagnostic performance, therapeutic selectivity, or clinical benefit can be established

Authors

Institutions

Publication Details

Journal
Kashmir Journal of Academic Research and Development
Published
2026-11-16
DOI
https://doi.org/10.71317/kjard.2.11.2026.1056
Primary Topic
Acute Lymphoblastic Leukemia research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development of Novel Biotechnological Approaches for The Diagnosis and Nanotechnology-Based Treatment of Pediatric Acute Lymphoblastic Leukemia: an Integrated Molecular Investigation

Muhammad Usman Mehmood, Syed Kashan Ali, Waqas khan, Nabiha Bashir et al.
1 links
Kashmir Journal of Academic Research and Development
Acute Lymphoblastic Leukemia research
article

Development of Novel Biotechnological Approaches for The Diagnosis and Nanotechnology-Based Treatment of Pediatric Acute Lymphoblastic Leukemia: an Integrated Molecular Investigation

Muhammad Usman Mehmood, Syed Kashan Ali, Waqas khan, Nabiha Bashir, Benish Iqbal, Muhammad Usman Mehmood, Dr. Nabiha Bashir, Dr. Syed Kashan Ali, Waqas Khan, Waqas Ahmad
article en

Abstract

Pediatric acute lymphoblastic leukemia (ALL) is a biologically heterogeneous hematological malignancy characterized by the abnormal proliferation of immature lymphoid cells. Although improvements in molecular classification, measurable residual disease (MRD) monitoring, and chemotherapy have substantially improved outcomes, challenges remain in detecting molecular subtypes, monitoring treatment response, and reducing treatment-associated toxicity. This study was designed to develop an integrated molecular diagnostic and nanotechnology-based therapeutic approach for pediatric B-cell acute lymphoblastic leukemia (B-ALL). A molecular assay framework was established for detecting selected leukemia-associated fusion transcripts, including ETV6::RUNX1, BCR::ABL1, TCF3::PBX1, and KMT2A-rearranged transcripts. Daunorubicin-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles were prepared using an oil-in-water emulsion-solvent evaporation method and evaluated using DLS, zeta-potential analysis, TEM, and FTIR. NALM-6 B-ALL cells were used as a leukemia cell model, while a non-malignant cell model was included to assess preliminary selectivity. In the illustrative dataset, daunorubicin-loaded PLGA nanoparticles had a mean hydrodynamic diameter of 186.4 ± 8.7 nm, a polydispersity index of 0.19 ± 0.03, and a zeta potential of −21.6 ± 2.4 mV. The molecular assay framework showed illustrative sensitivities of 95.0–100% and specificities of 96.0–100%, depending on the target. Nanoparticle-associated daunorubicin produced concentration-dependent reductions in NALM-6 cell viability and increased Annexin V-positive cells, with increased BAX and CASP3 expression and decreased BCL2 expression. Drug release was greater under the simulated acidic condition (pH 5.5) than at pH 7.4. These findings are hypothetical and require experimental validation. Further investigation using independent patient samples, multiple leukemia cell lines, and appropriate in vivo models is necessary before diagnostic performance, therapeutic selectivity, or clinical benefit can be established

Kashmir Journal of Academic Research and DevelopmentVol. 2(11)
Xuzhou Medical College (CN), Kohat University of Science and Technology (PK), Government of Pakistan (PK), Xuzhou Children Hospital (CN), University of Agriculture Faisalabad (PK)
Good health and well-being
Acute Lymphoblastic Leukemia research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon